News / Taiwan / economic_daily
Jinghua Biomedical Debuts on Taipei Exchange, Targets Global Expansion
Health Services · Medical/Nursing Services · economic_daily · 2026-10-15
7806
Jinghua Biomedical officially listed on the Taipei Exchange yesterday, with plans to leverage expanded production capacity and new international partnerships to grow its market share.
What Happened
Market Debut: Jinghua Biomedical successfully listed on the Taipei Exchange yesterday with an offering price of NT$55 per share, closing at NT$56.1. This milestone marks the company's entry into the public market, providing a foundation for future growth and capital management.
Capacity Expansion: Chairman Chen Chun-hung stated that the activation of the second plant and the implementation of smart warehousing will double the company's production capacity. These infrastructure improvements are critical for meeting increasing demand from both domestic and international clients.
Global Strategy: The company is actively expanding its footprint in Southeast Asia and North America through international trade shows and strengthened partnerships. This strategy aims to diversify revenue streams and enhance the company's global presence.
Client Growth: Jinghua Biomedical has successfully onboarded several new brand owners and large-scale distributors this year, significantly broadening its customer base. The company remains committed to optimizing its product mix to ensure long-term operational stability.